Global /Canada /Healthcare /Biotechnology /IBO

Universal Ibogaine Inc.

IBO

• TSXV: IBO • Delayed

0.0050CAD -50%

0.0036 USD

As of 5 June 2026, Universal Ibogaine Inc. has a market cap of $1.13M USD, ranking #48305 globally and #2665 in Canada. It ranks #4294 in the Healthcare sector, and #837 in the Biotechnology industry.

Global Rank

48305

Country Rank

2665

Sector Rank

4294

Industry Rank

837

Key Stats

Market Cap

$1.13MUSD

1.56M CAD

Enterprise Value

$2.88MUSD

4.01M CAD

Revenue (TTM)

$1.48MUSD

2.06M CAD

EBITDA (TTM)

-$257.77KUSD

-358.28K CAD

Net Income (TTM)

-$1.06MUSD

-1.48M CAD

EBITDA Margin

-17%

Profit Margin

-72%

PS Ratio

0.8

PB Ratio

5.7

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Biotechnology

CEO

Nicholas Karos open_in_new

Website

universalibogaine.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-50%	-50%	-50%	-50%	-80%	0%	-75%	-75%	-97%

News

Markets

Exchange	Ticker	Price	Quotes
TSX Venture Exchange (TSXV) MIC: XTSX PRIMARY	IBO Universal Ibogaine Inc ISIN: CA91360F1099 Shares Out.: Shares Outstanding: 274.826M¹ Shares Float: 235.471M² TV: TradingView: TSXV: IBO SA: Stock Analysis: TSXV: IBO YF: Yahoo Finance: IBO.V GF: Google Finance: CVE: IBO BA: Barron's: IBO MS: Morningstar: XTSX: IBO	0.0050 CAD	TV: TradingView: TSXV: IBO SA: Stock Analysis: TSXV: IBO YF: Yahoo Finance: IBO.V GF: Google Finance: CVE: IBO BA: Barron's: IBO MS: Morningstar: XTSX: IBO
Cboe Canada (NEO) MIC: NEOE	IBO Universal Ibogaine Inc ISIN: CA91360F1099 TV: TradingView: NEO: IBO SA: Stock Analysis: NEO: IBO YF: Yahoo Finance: IBO.NE GF: Google Finance: NEO: IBO BA: Barron's: IBO MS: Morningstar: NEOE: IBO	0.0050 CAD	TV: TradingView: NEO: IBO SA: Stock Analysis: NEO: IBO YF: Yahoo Finance: IBO.NE GF: Google Finance: NEO: IBO BA: Barron's: IBO MS: Morningstar: NEOE: IBO
OTC Markets (OTCMKTS / OTC) MIC: OTCM	IBOGF Universal Ibogaine Inc ISIN: CA91360F1099 TV: TradingView: OTC: IBOGF SA: Stock Analysis: OTC: IBOGF YF: Yahoo Finance: IBOGF GF: Google Finance: OTCMKTS: IBOGF BA: Barron's: IBOGF MS: Morningstar: PINX: IBOGF	0.0140 USD	TV: TradingView: OTC: IBOGF SA: Stock Analysis: OTC: IBOGF YF: Yahoo Finance: IBOGF GF: Google Finance: OTCMKTS: IBOGF BA: Barron's: IBOGF MS: Morningstar: PINX: IBOGF

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Universal Ibogaine Inc.

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.

Similar Companies

Industry: Biotechnology (Canada)

Name	Market Cap (USD) diff.	PE	Country
Aurinia Pharmaceuticals Inc. NASDAQ: AUPH	$1.99B 176K%	7.4	Canada
AbCellera Biologics Inc. NASDAQ: ABCL	$1.16B 103K%	-	Canada
Eupraxia Pharmaceuticals Inc. TSX: EPRX	$432.32M 600.89M CAD 38K%	-	Canada
NervGen Pharma Corp. TSXV: NGEN	$295.12M 410.19M CAD 26K%	-	Canada
Cybin Inc. NEO: CYBN	$254.07M 353.13M CAD 22K%	-	Canada
Cardiol Therapeutics Inc. TSX: CRDL	$149.71M 208.08M CAD 13K%	-	Canada

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 16M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 14M%	19.0	United States
argenx SE EBR: ARGX	$48.08B 41.39B EUR 4M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.48B 68.19T KRW 4M%	35.5	South Korea
CSL Ltd. ASX: CSL	$43.01B 60.27B AUD 4M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.72B 33.71B CHF 4M%	37.2	Switzerland

chevron_leftBack